Antidepressant dosage form

Abstract

The invention pertains to a dosage form 10 and to administering an antidepressant medicament 16 for an extended period of time in a rate-known dose.

1 .- 5 . (canceled)  
   
   
       6 . A dosage form for the oral delivery of 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-cyclohexanol or its pharmaceutically acceptable salts to an environment of use, wherein the dosage form comprises: 
 (a) a wall comprising at least in part a composition permeable to the passage of fluid, but not to the passage of 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-cyclohexanol or its pharmaceutically acceptable salts which wall surrounds:    (b) a compartment;    (c) a drug composition in the compartment comprising 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-cyclohexanol or its pharmaceutically acceptable salts:    (d) a displacement composition in the compartment comprising an osmotically active compound; and    (e) an exit passageway in the dosage form for delivering the drug composition from the dosage form.    
   
   
       7 . (canceled)